Rob Ball, CEO of Shoulder Innovations, signaled that the agreement secures the company’s intellectual property portfolio, a move he described as essential for maintaining their commitment to shoulder arthroplasty development. By resolving these court proceedings, the company aims to refocus its resources on its core ecosystem, which includes implant systems, preoperative planning tools, and procedural efficiency technologies designed for the surgical care market. The settlement allows both firms to move past the distraction of litigation, enabling the ongoing delivery of orthopedic solutions to surgeons and patients across various clinical sites.